Related Experiment Video
Updated: Oct 22, 2025

11:32
Evaluating Cell Death Signaling by Immunofluorescence in a Rat Model of Ischemic Stroke
Published on: January 3, 2025
1.2K
The Nrf2 Pathway in Ischemic Stroke: A Review.
Marcelo Farina1, Leonardo Eugênio Vieira1, Brigitta Buttari2
1Department of Biochemistry, Federal University of Santa Catarina, 88040-900 Florianópolis, Brazil.
Molecules (Basel, Switzerland)
|August 27, 2021
Summary
Nuclear factor erythroid 2-related factor 2 (Nrf2) shows protective potential against ischemic stroke by regulating antioxidant defenses. However, challenges exist in developing Nrf2 activators for acute stroke treatment due to cellular response times.
Area of Science:
- Neuroscience
- Biochemistry
- Pharmacology
Background:
- Ischemic stroke is a leading cause of death and disability worldwide.
- Current treatments for acute ischemic stroke have limitations and do not address the post-stroke oxidative cascade.
- The transcription factor Nrf2 regulates antioxidant and defense proteins, making it a potential therapeutic target.
Purpose of the Study:
- To review the protective role of Nrf2 in experimental ischemic stroke models.
- To highlight molecular events in the ischemic cascade modulated by Nrf2.
- To discuss challenges in developing Nrf2 activators for acute ischemic stroke treatment.
Main Methods:
- Review of studies on Nrf2 in experimental ischemic stroke models.
- Analysis of molecular events in the ischemic cascade.
- Discussion of pharmacological strategies targeting Nrf2.
Main Results:
- Nrf2 activation demonstrates a protective effect in experimental ischemic stroke.
- Nrf2 modulates key molecular events within the ischemic cascade.
- The therapeutic application of Nrf2 activators faces challenges related to cellular response times.
Conclusions:
- Nrf2 is a promising target for mitigating oxidative stress in ischemic stroke.
- Further research is needed to overcome the challenges of using Nrf2 activators in acute stroke settings.
- The temporal dynamics of Nrf2 activation present a hurdle for immediate clinical application.
Related Concept Videos
Ischemic Heart Disease: Overview
2.0K
Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
2.0K
NF-κB-dependent Signaling Pathway
8.0K
The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
NF-κB-dependent Signaling Mechanism
The...
8.0K

